Abstract
Immuno-oncologics (IOs) differ from chemotherapies as they prime the patient’s immune system to attack the tumor, rather than directly destroying cancer cells. The IO mechanism of action leads to durable...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have